The primary objective of the study was met: in fact, gefitinib was clearly superior to carboplatin–paclitaxel ... common adverse effects were acneiform rash and diarrhea, whereas in those ...

Thymic carcinoma, a rare cancer, is often associated with poor prognosis in advanced or recurrent stages. However, its rarity has delayed the development of novel pharmacotherapy. Now, researchers ...